Harvard stem cell scientists have identified a mutation in human cases of acute lymphoblastic leukemia that likely drives relapse. The research, published in Cancer Cell, could translate into improved patien ...
Mar 06, 2014
5 / 5 (2) | 0
Infecting just one tumor with a virus could boost the systemic effectiveness of cancer immunotherapy
A Ludwig Cancer Research study suggests that the clinical efficacy of checkpoint blockade, a powerful new strategy to harness the immune response to treat cancers, might be dramatically improved if combined with oncolytic ...
Mar 05, 2014
4.9 / 5 (11) | 0